The Winter 2017 edition of the newsletter on SWOG's Lung-MAP precision medicine trial is out. Lung-MAP is NCI's first precision trial, and testing new treatments for squamous cell lung cancer.

The newsletter has the latest on a reopened sub-study, a trial update at the World Conference on Lung Cancer last month in Japan, and a December 7 webinar for site staff, who can get the study status and all their questions answered by Lung-MAP leaders on the call. Read the new edition here.

Other Recent Stories

SWOG Front Line banner
Aug 21, 2026
Turning AI to finding clinical trials for patients
Federal and Industry Sponsorship in US Cancer Clinical Trials
Aug 20, 2026
New research details the vital, unique role federal support plays in cancer clinical research
SWOG Front Line banner
Aug 14, 2026
Three studies from our NCORP RB have reported primary results recently